| class name | count |
|---|---|
| rosids | 4 |
| Magnoliophyta | 1 |
| class name | count |
|---|---|
| Rosaceae | 1 |
| Brassicaceae | 1 |
| Rutaceae | 1 |
| Piperaceae | 1 |
| Elaeagnaceae | 1 |
| br08003 Category | # of metabolite |
|---|
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00001179
|
Vitamin C
/ L-Ascorbate / L-Ascorbic acid / (+)-Ascorbic acid |
CHEMBL196
CHEMBL1161421 |
D001205
|
104 / 58 / 50 | 254 / 98 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001179 | 1 / 0 |
| Q9H6Z9 | Egl nine homolog 3 | Enzyme | C00001179 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001179 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001179 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001179 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00001179 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001179 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001179 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001179 | 0 / 0 |
| P04746 | Pancreatic alpha-amylase | Hydrolase | C00001179 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00001179 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001179 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001179 | 0 / 0 |
| Q9UGH3 | Solute carrier family 23 member 2 | Ascorbate | C00001179 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001179 | 2 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001179 | 11 / 10 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001179 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001179 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001179 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001179 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001179 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001179 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001179 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001179 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001179 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001179 | 0 / 1 |
| Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001179 | 1 / 1 |
| P13674 | Prolyl 4-hydroxylase subunit alpha-1 | Enzyme | C00001179 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001179 | 1 / 8 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00001179 | 2 / 3 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001179 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001179 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001179 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001179 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001179 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001179 | 0 / 0 |
| Q96KS0 | Egl nine homolog 2 | Enzyme | C00001179 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001179 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001179 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001179 | 1 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001179 | 0 / 0 |
| Q9NWT6 | Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | C00001179 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001179 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001179 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001179 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001179 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001179 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001179 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001179 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001179 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001179 | 1 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001179 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001179 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001179 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001179 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001179 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001179 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001179 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001179 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001179 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00001179 | 4 / 2 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001179 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001179 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001179 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001179 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001179 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001179 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001179 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001179 | 0 / 0 |
| P04745 | Alpha-amylase 1 | Enzyme | C00001179 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001179 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001179 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001179 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001179 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001179 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001179 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001179 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001179 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001179 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001179 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001179 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001179 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001179 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001179 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001179 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001179 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001179 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001179 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001179 | 4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001179 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001179 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001179 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001179 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001179 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001179 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 16 | AARS, CMT2N | alanyl-tRNA synthetase (EC:6.1.1.7) |
C00001179
|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001179
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001179
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001179
|
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001179
|
| 59272 | ACE2, ACEH | angiotensin I converting enzyme 2 (EC:3.4.17.23) |
C00001179
|
| 59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00001179
|
| 112 | ADCY6, AC6 | adenylate cyclase 6 (EC:4.6.1.1) |
C00001179
|
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00001179
|
| 248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00001179
|
| 290 | ANPEP, APN, CD13, GP150, LAP1, P150, PEPN | alanyl (membrane) aminopeptidase (EC:3.4.11.2) |
C00001179
|
| 301 | ANXA1, ANX1, LPC1 | annexin A1 |
C00001179
|
| 335 | APOA1 | apolipoprotein A-I |
C00001179
|
| 338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001179
|
| 55937 | APOM, G3a, HSPC336, NG20, apo-M | apolipoprotein M |
C00001179
|
| 351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00001179
|
| 360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00001179
|
| 397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001179
|
| 440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00001179
|
| 467 | ATF3 | activating transcription factor 3 |
C00001179
|
| 9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) |
C00001179
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001179
|
| 27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001179
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001179
|
| 79370 | BCL2L14, BCLG | BCL2-like 14 (apoptosis facilitator) |
C00001179
|
| 632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00001179
|
| 12095 |
C00001179
|
||
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00001179
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001179
|
| 699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00001179
|
| 768 | CA9, CAIX, MN | carbonic anhydrase IX (EC:4.2.1.1) |
C00001179
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001179
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001179
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00001179
|
| 875 | CBS, HIP4 | cystathionine-beta-synthase (EC:4.2.1.22) |
C00001179
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001179
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001179
|
| 894 | CCND2, KIAK0002 | cyclin D2 |
C00001179
|
| 100133941 | CD24, CD24A | CD24 molecule |
C00001179
|
| 947 | CD34 | CD34 molecule |
C00001179
|
| 958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00001179
|
| 990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00001179
|
| 728642 | CDK11A, CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, PITSLRE, p58GTA | cyclin-dependent kinase 11A (EC:2.7.11.22) |
C00001179
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001179
|
| 629 | CFB, AHUS4, BF, BFD, CFAB, FB, FBI12, GBG, H2-Bf, PBF2 | complement factor B (EC:3.4.21.47) |
C00001179
|
| 1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001179
|
| 11113 | CIT, CRIK, STK21 | citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1) |
C00001179
|
| 1264 | CNN1, SMCC, Sm-Calp | calponin 1, basic, smooth muscle |
C00001179
|
| 1270 | CNTF, HCNTF | ciliary neurotrophic factor |
C00001179
|
| 1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00001179
|
| 1380 | CR2, C3DR, CD21, CR, CVID7, SLEB9 | complement component (3d/Epstein Barr virus) receptor 2 |
C00001179
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001179
|
| 1519 | CTSO, CTSO1 | cathepsin O (EC:3.4.22.42) |
C00001179
|
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00001179
|
| 6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00001179
|
| 4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00001179
|
| 643 | CXCR5, BLR1, CD185, MDR15 | chemokine (C-X-C motif) receptor 5 |
C00001179
|
| 79901 | CYBRD1, CYB561A2, DCYTB, FRRS3 | cytochrome b reductase 1 |
C00001179
|
| 1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00001179
|
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001179
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001179
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001179
|
| 1556 | CYP2B7P, CYP2B, CYP2B7, CYP2B7P1 | cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene |
C00001179
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001179
|
| 22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001179
|
| 9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00001179
|
| 54431 | DNAJC10, ERdj5, JPDI, MTHr, PDIA19 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
C00001179
|
| 1773 | DNASE1, DNL1, DRNI | deoxyribonuclease I (EC:3.1.21.1) |
C00001179
|
| 1803 | DPP4, ADABP, ADCP2, CD26, DPPIV, TP103 | dipeptidyl-peptidase 4 (EC:3.4.14.5) |
C00001179
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001179
|
| 1908 | EDN3, ET-3, ET3, HSCR4, PPET3, WS4B | endothelin 3 |
C00001179
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00001179
|
| 112399 | EGLN3, HIFP4H3, HIFPH3, PHD3 | egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29) |
C00001179
|
| 8894 | EIF2S2, EIF2, EIF2B, EIF2beta, PPP1R67, eIF-2-beta | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa |
C00001179
|
| 8661 | EIF3A, EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta, p180, p185 | eukaryotic translation initiation factor 3, subunit A |
C00001179
|
| 8343525 |
C00001179
|
||
| 1973 | EIF4A1, DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I | eukaryotic translation initiation factor 4A1 (EC:3.6.4.13) |
C00001179
|
| 2012 | EMP1, CL-20, EMP-1, TMP | epithelial membrane protein 1 |
C00001179
|
| 2014 | EMP3, YMP | epithelial membrane protein 3 |
C00001179
|
| 2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00001179
|
| 2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00001179
|
| 2053 | EPHX2, CEH, SEH | epoxide hydrolase 2, cytoplasmic (EC:3.3.2.10 3.1.3.76) |
C00001179
|
| 2058 | EPRS, EARS, GLUPRORS, PARS, QARS, QPRS | glutamyl-prolyl-tRNA synthetase (EC:6.1.1.15 6.1.1.17) |
C00001179
|
| 2172 | FABP6, I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP | fatty acid binding protein 6, ileal |
C00001179
|
| 2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00001179
|
| 2326 | FMO1 | flavin containing monooxygenase 1 (EC:1.14.13.8) |
C00001179
|
| 2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00001179
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00001179
|
| 2302 | FOXJ1, FKHL13, HFH-4, HFH4 | forkhead box J1 |
C00001179
|
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00001179
|
| 2535 | FZD2, Fz2, fz-2, fzE2, hFz2 | frizzled family receptor 2 |
C00001179
|
| 50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 |
C00001179
|
| 2580 | GAK, DNAJ26, DNAJC26 | cyclin G associated kinase (EC:2.7.11.1) |
C00001179
|
| 2617 | GARS, CMT2D, DSMAV, GlyRS, HMN5, SMAD1 | glycyl-tRNA synthetase (EC:6.1.1.14) |
C00001179
|
| 2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00001179
|
| 2674 | GFRA1, GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1 | GDNF family receptor alpha 1 |
C00001179
|
| 2744 | GLS, AAD20, GAC, GAM, GLS1, KGA | glutaminase (EC:3.5.1.2) |
C00001179
|
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001179
|
| 2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00001179
|
| 2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00001179
|
| 2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00001179
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001179
|
| 2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00001179
|
| 2965 | GTF2H1, BTF2, P62, TFB1, TFIIH | general transcription factor IIH, polypeptide 1, 62kDa |
C00001179
|
| 3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00001179
|
| 9843 | HEPH, CPL | hephaestin |
C00001179
|
| 9709 | HERPUD1, HERP, Mif1, SUP | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
C00001179
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001179
|
| 3098 | HK1, HK1-ta, HK1-tb, HK1-tc, HKD, HKI, HMSNR, HXK1 | hexokinase 1 (EC:2.7.1.1) |
C00001179
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001179
|
| 3240 | HP, BP, HP2ALPHA2, HPA1S | haptoglobin |
C00001179
|
| 3283 | HSD3B1, 3BETAHSD, HSD3B, HSDB3, HSDB3A, I, SDR11E1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1) |
C00001179
|
| 3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00001179
|
| 3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00001179
|
| 3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00001179
|
| 3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00001179
|
| 3347 | HTN3, HIS2, HTN2, HTN5 | histatin 3 |
C00001179
|
| 3376 | IARS, IARS1, ILERS, ILRS, IRS, PRO0785 | isoleucyl-tRNA synthetase (EC:6.1.1.5) |
C00001179
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001179
|
| 8870 | IER3, DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 | immediate early response 3 |
C00001179
|
| 3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00001179
|
| 10320 | IKZF1, Hs.54452, IK1, IKAROS, LYF1, PRO0758, ZNFN1A1, hIk-1 | IKAROS family zinc finger 1 (Ikaros) |
C00001179
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001179
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001179
|
| 3745 | KCNB1, DRK1, KV2.1, h-DRK1 | potassium voltage-gated channel, Shab-related subfamily, member 1 |
C00001179
|
| 3791 | KDR, CD309, FLK1, VEGFR, VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) |
C00001179
|
| 9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00001179
|
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00001179
|
| 3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00001179
|
| 4017 | LOXL2, LOR2, WS9-14 | lysyl oxidase-like 2 (EC:1.4.3.-) |
C00001179
|
| 4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00001179
|
| 23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00001179
|
| 10892 | MALT1, IMD12, MLT, MLT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) |
C00001179
|
| 5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00001179
|
| 5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00001179
|
| 4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00001179
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001179
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001179
|
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001179
|
| 4173 | MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21 | minichromosome maintenance complex component 4 (EC:3.6.4.12) |
C00001179
|
| 4224 | MEP1A, PPHA | meprin A, alpha (PABA peptide hydrolase) (EC:3.4.24.18) |
C00001179
|
| 4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001179
|
| 4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00001179
|
| 4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00001179
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00001179
|
| 4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00001179
|
| 4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001179
|
| 4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00001179
|
| 4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00001179
|
| 11223 | MST1L, BRF-1, D1F15S1A, MSPL-7, MSPL7, MST1P9, MSTP7, MSTP9 | macrophage stimulating 1-like |
C00001179
|
| 4504 | MT3, GIF, GIFB, GRIF, ZnMT3 | metallothionein 3 |
C00001179
|
| 10797 | MTHFD2, NMDMC | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15) |
C00001179
|
| 4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00001179
|
| 4640 | MYO1A, BBMI, DFNA48, MIHC, MYHL | myosin IA |
C00001179
|
| 4677 | NARS, ASNRS, NARS1 | asparaginyl-tRNA synthetase (EC:6.1.1.22) |
C00001179
|
| 10397 | NDRG1, CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL, NDR1, NMSL, PROXY1, RIT42, RTP, TARG1, TDD5 | N-myc downstream regulated 1 |
C00001179
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00001179
|
| 4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00001179
|
| 4814 | NINJ1, NIN1, NINJURIN | ninjurin 1 |
C00001179
|
| 7080 | NKX2-1, BCH, BHC, NK-2, NKX2.1, NKX2A, TEBP, TITF1, TTF-1, TTF1 | NK2 homeobox 1 |
C00001179
|
| 4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00001179
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001179
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001179
|
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00001179
|
| 8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00001179
|
| 4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00001179
|
| 10956 | OS9, ERLEC2, OS-9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
C00001179
|
| 8974 | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II (EC:1.14.11.2) |
C00001179
|
| 54681 | P4HTM, EGLN4, HIFPH4, P4H-TM, PH-4, PH4, PHD4 | prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
C00001179
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001179
|
| 5106 | PCK2, PEPCK, PEPCK-M, PEPCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32) |
C00001179
|
| 64714 | PDIA2, PDA2, PDI, PDIP, PDIR | protein disulfide isomerase family A, member 2 (EC:5.3.4.1) |
C00001179
|
| 2923 | PDIA3, ER60, ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC | protein disulfide isomerase family A, member 3 (EC:5.3.4.1) |
C00001179
|
| 26227 | PHGDH, 3-PGDH, 3PGDH, PDG, PGAD, PGD, PGDH, SERA | phosphoglycerate dehydrogenase (EC:1.1.1.95) |
C00001179
|
| 22822 | PHLDA1, DT1P1B11, PHRIP, TDAG51 | pleckstrin homology-like domain, family A, member 1 |
C00001179
|
| 7262 | PHLDA2, BRW1C, BWR1C, HLDA2, IPL, TSSC3 | pleckstrin homology-like domain, family A, member 2 |
C00001179
|
| 11145 | PLA2G16, AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3 | phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32) |
C00001179
|
| 5340 | PLG | plasminogen (EC:3.4.21.7) |
C00001179
|
| 5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00001179
|
| 5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00001179
|
| 5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00001179
|
| 5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001179
|
| 5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00001179
|
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00001179
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001179
|
| 5588 | PRKCQ, PRKCT, nPKC-theta | protein kinase C, theta (EC:2.7.11.13) |
C00001179
|
| 38175 |
C00001179
|
||
| 5702 | PSMC3, TBP1 | proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
C00001179
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001179
|
| 5865 | RAB3B | RAB3B, member RAS oncogene family |
C00001179
|
| 5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00001179
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00001179
|
| 5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00001179
|
| 25788 | RAD54B, RDH54 | RAD54 homolog B (S. cerevisiae) |
C00001179
|
| 1827 | RCAN1, ADAPT78, CSP1, DSC1, DSCR1, MCIP1, RCN1 | regulator of calcineurin 1 |
C00001179
|
| 860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00001179
|
| 795 | S100G, CABP, CABP1, CABP9K, CALB3 | S100 calcium binding protein G |
C00001179
|
| 5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00001179
|
| 83667 | SESN2, HI95, SES2, SEST2 | sestrin 2 |
C00001179
|
| 6439 | SFTPB, PSP-B, SFTB3, SFTP3, SMDP1, SP-B | surfactant protein B |
C00001179
|
| 6472 | SHMT2, GLYA, SHMT | serine hydroxymethyltransferase 2 (mitochondrial) (EC:2.1.2.1) |
C00001179
|
| 6476 | SI | sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48) |
C00001179
|
| 4891 | SLC11A2, DCT1, DMT1, NRAMP2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
C00001179
|
| 10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 |
C00001179
|
| 9963 | SLC23A1, SLC23A2, SVCT1, YSPL3 | solute carrier family 23 (ascorbic acid transporter), member 1 |
C00001179
|
| 9962 | SLC23A2, NBTL1, SLC23A1, SVCT2, YSPL2 | solute carrier family 23 (ascorbic acid transporter), member 2 |
C00001179
|
| 79677 | SMC6, SMC-6, SMC6L1, hSMC6 | structural maintenance of chromosomes 6 |
C00001179
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001179
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001179
|
| 6657 | SOX2, ANOP3, MCOPS3 | SRY (sex determining region Y)-box 2 |
C00001179
|
| 6667 | SP1 | Sp1 transcription factor |
C00001179
|
| 6670 | SP3, SPR2 | Sp3 transcription factor |
C00001179
|
| 6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor |
C00001179
|
| 6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00001179
|
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00001179
|
| 6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00001179
|
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00001179
|
| 9262 | STK17B, DRAK2 | serine/threonine kinase 17b (EC:2.7.11.1) |
C00001179
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001179
|
| 6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001179
|
| 20888 |
C00001179
|
||
| 6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00001179
|
| 6876 | TAGLN, SM22, SMCC, TAGLN1, WS3-10 | transgelin |
C00001179
|
| 6897 | TARS, ThrRS | threonyl-tRNA synthetase (EC:6.1.1.3) |
C00001179
|
| 6901 | TAZ, BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, Taz1 | tafazzin |
C00001179
|
| 7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00001179
|
| 7032 | TFF2, SML1, SP | trefoil factor 2 |
C00001179
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00001179
|
| 7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00001179
|
| 4071 | TM4SF1, H-L6, L6, M3S1, TAAL6 | transmembrane 4 L six family member 1 |
C00001179
|
| 164656 | TMPRSS6, IRIDA | transmembrane protease, serine 6 |
C00001179
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001179
|
| 4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00001179
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00001179
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001179
|
| 11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) |
C00001179
|
| 57761 | TRIB3, C20orf97, NIPK, SINK, SKIP3, TRB3 | tribbles pseudokinase 3 |
C00001179
|
| 9322 | TRIP10, CIP4, HSTP, STOT, STP | thyroid hormone receptor interactor 10 |
C00001179
|
| 7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00001179
|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001179
|
| 7319 | UBE2A, HHR6A, MRXS30, MRXSN, RAD6A, UBC2 | ubiquitin-conjugating enzyme E2A (EC:6.3.2.19) |
C00001179
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00001179
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00001179
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00001179
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00001179
|
| 7428 | VHL, HRCA1, RCA1, VHL1, pVHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
C00001179
|
| 55350 | VNN3, HSA238982 | vanin 3 |
C00001179
|
| 7443 | VRK1, PCH1, PCH1A | vaccinia related kinase 1 (EC:2.7.11.1) |
C00001179
|
| 7453 | WARS, GAMMA-2, IFI53, IFP53 | tryptophanyl-tRNA synthetase (EC:6.1.1.2) |
C00001179
|
| 10352 | WARS2, TrpRS | tryptophanyl tRNA synthetase 2, mitochondrial (EC:6.1.1.2) |
C00001179
|
| 25937 | WWTR1, TAZ | WW domain containing transcription regulator 1 |
C00001179
|
| 7512 | XPNPEP2, APP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound (EC:3.4.11.9) |
C00001179
|
| 7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00001179
|
| 7718 | ZNF165, CT53, LD65, ZSCAN7 | zinc finger protein 165 |
C00001179
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D058186 | Acute Kidney Injury |
C00001179
|
| D055371 | Acute Lung Injury |
C00001179
|
| D000647 | Amnesia |
C00001179
|
| D000740 | Anemia |
C00001179
|
| D018798 | Anemia, Iron-Deficiency |
C00001179
|
| D000749 | Anemia, Megaloblastic |
C00001179
|
| D000756 | Anemia, Sideroblastic |
C00001179
|
| D001206 | Ascorbic Acid Deficiency |
C00001179
|
| D001424 | Bacterial Infections |
C00001179
|
| D001766 | Blindness |
C00001179
|
| D001847 | Bone Diseases |
C00001179
|
| D001927 | Brain Diseases |
C00001179
|
| D002545 | Brain Ischemia |
C00001179
|
| D001943 | Breast Neoplasms |
C00001179
|
| D002277 | Carcinoma |
C00001179
|
| D006528 | Carcinoma, Hepatocellular |
C00001179
|
| D009202 | Cardiomyopathies |
C00001179
|
| D018376 | Cardiovascular Abnormalities |
C00001179
|
| D002318 | Cardiovascular Diseases |
C00001179
|
| D002375 | Catalepsy |
C00001179
|
| D002386 | Cataract |
C00001179
|
| D002471 | Cell Transformation, Neoplastic |
C00001179
|
| D002607 | Charcot-Marie-Tooth Disease |
C00001179
|
| D002869 | Chromosome Aberrations |
C00001179
|
| D003139 | Common Cold |
C00001179
|
| D020918 | Complex Regional Pain Syndromes |
C00001179
|
| D003327 | Coronary Disease |
C00001179
|
| D003681 | Dehydration |
C00001179
|
| D003924 | Diabetes Mellitus, Type 2 |
C00001179
|
| D003928 | Diabetic Nephropathies |
C00001179
|
| D003930 | Diabetic Retinopathy |
C00001179
|
| D056486 | Drug-Induced Liver Injury |
C00001179
|
| D062787 | Drug Overdose |
C00001179
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001179
|
| C538011 | Eales disease |
C00001179
|
| D004890 | Erythema |
C00001179
|
| D005221 | Fatigue |
C00001179
|
| D006029 | Glycosuria |
C00001179
|
| D006130 | Growth Disorders |
C00001179
|
| D006212 | Hallucinations |
C00001179
|
| D006330 | Heart Defects, Congenital |
C00001179
|
| D006548 | Hernia, Diaphragmatic |
C00001179
|
| D015658 | HIV Infections |
C00001179
|
| D006959 | Hyperoxaluria |
C00001179
|
| D006965 | Hyperplasia |
C00001179
|
| D006973 | Hypertension |
C00001179
|
| D006977 | Hypertension, Renal |
C00001179
|
| D007022 | Hypotension |
C00001179
|
| D007037 | Hypothyroidism |
C00001179
|
| 146850 | IMMUNE SUPPRESSION |
C00001179
|
| D007674 | Kidney Diseases |
C00001179
|
| D007683 | Kidney Tubular Necrosis, Acute |
C00001179
|
| D007859 | Learning Disorders |
C00001179
|
| D007945 | Leukemia, Lymphoid |
C00001179
|
| D008103 | Liver Cirrhosis |
C00001179
|
| D008114 | Liver Neoplasms, Experimental |
C00001179
|
| D008171 | Lung Diseases |
C00001179
|
| D008175 | Lung Neoplasms |
C00001179
|
| D020149 | Manganese Poisoning |
C00001179
|
| D008630 | Mercury Poisoning |
C00001179
|
| D048629 | Micronuclei, Chromosome-Defective |
C00001179
|
| D009120 | Muscle Cramp |
C00001179
|
| D009135 | Muscular Diseases |
C00001179
|
| D009203 | Myocardial Infarction |
C00001179
|
| D009325 | Nausea |
C00001179
|
| D009336 | Necrosis |
C00001179
|
| D009369 | Neoplasms |
C00001179
|
| D009374 | Neoplasms, Experimental |
C00001179
|
| D009395 | Nephritis, Interstitial |
C00001179
|
| D053040 | Nephrolithiasis |
C00001179
|
| D009410 | Nerve Degeneration |
C00001179
|
| D009422 | Nervous System Diseases |
C00001179
|
| D009765 | Obesity |
C00001179
|
| D009845 | Oligospermia |
C00001179
|
| D010149 | Pain, Postoperative |
C00001179
|
| D010212 | Papilloma |
C00001179
|
| D016491 | Peripheral Vascular Diseases |
C00001179
|
| D011041 | Poisoning |
C00001179
|
| D011230 | Precancerous Conditions |
C00001179
|
| D011471 | Prostatic Neoplasms |
C00001179
|
| D011507 | Proteinuria |
C00001179
|
| D011561 | Pseudoxanthoma Elasticum |
C00001179
|
| D011605 | Psychoses, Substance-Induced |
C00001179
|
| D011654 | Pulmonary Edema |
C00001179
|
| D011657 | Pulmonary Eosinophilia |
C00001179
|
| D011658 | Pulmonary Fibrosis |
C00001179
|
| D051437 | Renal Insufficiency |
C00001179
|
| D012174 | Retinitis Pigmentosa |
C00001179
|
| D012614 | Scurvy |
C00001179
|
| D012640 | Seizures |
C00001179
|
| D012871 | Skin Diseases |
C00001179
|
| D013226 | Status Epilepticus |
C00001179
|
| D013274 | Stomach Neoplasms |
C00001179
|
| D013276 | Stomach Ulcer |
C00001179
|
| D020521 | Stroke |
C00001179
|
| D013375 | Substance Withdrawal Syndrome |
C00001179
|
| D013921 | Thrombocytopenia |
C00001179
|
| D001749 | Urinary Bladder Neoplasms |
C00001179
|